Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTyratech Regulatory News (TYR)

  • There is currently no data for TYR

Share Migration

28 Mar 2013 16:15

RNS Number : 1999B
TyraTech, Inc.
28 March 2013
Β 

ο»Ώ

28 March 2013

Β 

Β 

TYRATECH, INC.

("TyraTech" or the "Company")

Β 

Migration of Shares

Β 

TyraTech, Inc. (AIM: TYR and TYRU), a natural life sciences company, announces that certain of its common shares of US$0.001 in the Company ("Common Shares"), which trade on the Company's restricted trading line under TIDM 'TYR' with ISIN number USU890581080, may now be eligible to migrate to the Company's unrestricted trading line under TIDM 'TYRU' with ISIN number US90239R2031.

Β 

Removal of the trading restrictions allows the shares to be:

Β 

Β·; transferred to its unrestricted trading line (TIDM: TYRU); and

Β·; settled (at the election of the shareholder), by means of Depositary Interests, through the CREST electronic settlement system.

Β 

TyraTech currently has a total of 108,176,305 Common Shares in issue, of which 1,084,413 are held in Treasury. 80,874,936 Common Shares trade under TIDM 'TYR' in a restricted manner as permitted by Regulation S promulgated under the U.S. Securities Act of 1933 (as amended). The Company's remaining 27,301,369 Common Shares in issue are unrestricted and trade under TIDM 'TYRU'. TyraTech believe that approximately 40.4 million of its Common Shares are currently eligible to migrate to the unrestricted line of shares.

Β 

In general, under U.S. securities law, Common Shares that have been in issue for more than one year and are not held by an 'affiliate' of the Company qualify for characterisation as unrestricted Common Shares ("Unrestricted Common Shares"). An affiliate for this purpose is a person that directly, or indirectly through one or more intermediaries, controls, or is controlled by, or is under common control with, the Company or a director or officer of the Company. Generally a beneficial owner of 10% of more of the issued Common Shares taking into account shares held and any options, warrants or other securities convertible or exercisable within 60 days will be considered an affiliate for this purpose.

Β 

All Unrestricted Common Shares are eligible for migration to, and trading on, the Company's unrestricted TYRU line.

Β 

All Common Shares not meeting the definition of Unrestricted Common Shares will continue to trade in a restricted manner under the Company's TYR line. There is no difference in entitlement between the Common Shares trading in the restricted line and those trading in the unrestricted line, but the TYRU line will serve to evidence the absence of restrictions on trading otherwise imposed by the U.S. Securities Act of 1933 (as amended) and will enable electronic settlement if a holder so desires.

Β 

The Company has sent letters with instructions to shareholders whose Common Shares it believes should be eligible for migration ("Eligible Shares") to the Company's unrestricted TYRU line.

Β 

To participate, holders of Eligible Shares mustΒ deliver their current restricted share certificates to the Company's transfer agent (Computershare Investor Services (Jersey) Limited, Queensway House, Hilgrove Street, St Helier, Jersey, JE1 1ES) together with the Letter of Transmittal which has also been sent to holders of Eligible Shares, by 3 May 2013. Holders of Eligible Shares will have the option to either receive an unrestricted certificate in return or have their Eligible Shares entered into CREST, which is a depositary interest facility that permits trading on the unrestricted TYRU line to be settled electronically.Β 

Β 

Shareholders in the Company who already hold unrestricted paper certificates can apply to have their certificates entered into CREST by completing a dematerialisation form and sending it to Computershare.

Β 

Copies of the letter to shareholders and the Letter of Transmittal (for eligible shareholders with restricted shares) and dematerialisation forms (for shareholders with unrestricted paper shares who wish to transfer to CREST) will be made available on the Company's website, www.tyratech.com.

Β 

Β 

For further information please contact:

Β 

TyraTech Inc.Alan Reade, Executive ChairmanTel: +1 919 415 4310

Β 

Bruno Jactel, Chief Executive Officer

Tel: +1 919 415 4280

Β 

N+1 Singer, Nominated Adviser and Joint BrokerAubrey Powell / Alex WrightTel: +44 20 7496 3000

Β 

First Columbus LLP, Joint BrokerChris CrawfordTel: +44 20 3002 2070

Β 

Walbrook, Financial PR and IR

Bob Huxford / Paul Cornelius / Guy McDougall

Tel + 44 20 7933 8792

Β 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
MSCEAKDPAFLDEFF
Date   Source Headline
24th Sep 20157:00 amRNSHalf Yearly Report
2nd Sep 20157:00 amRNSMigration of shares
6th Aug 20157:00 amRNSMigration of Shares
30th Jul 20154:38 pmRNSResult of AGM
3rd Jul 20155:04 pmRNSMigration of Shares
22nd Jun 20157:00 amRNSFinal Results
10th Jun 20152:22 pmRNSMigration of Shares
26th May 20157:01 amRNSSmartPak launches OutSmart insect repellent
21st May 20155:45 pmRNSMigration of Shares
22nd Apr 20157:00 amRNSDirector's Dealings
20th Apr 20157:00 amRNSEnvance LLC amended: Sharpened strategic focus
9th Apr 20151:14 pmRNSMigration of Shares
8th Apr 20157:00 amRNSListing with Walgreens in the USA
27th Mar 20159:41 amRNSMigration of Shares and Exercise of SARs
25th Mar 20157:00 amRNSVamousse now distributed by CVS in the USA
3rd Mar 20157:00 amRNSVamousse now listed by the top 3 distributors, USA
25th Feb 20157:00 amRNSLloyds and Day Lewis Pharmacy listings
16th Feb 20155:01 pmRNSDirector's Dealings
2nd Feb 20157:00 amRNSVamousse at Walmart and Cardinal Health USA
26th Jan 20157:00 amRNSInnovators and Investors Forum, London
15th Jan 20157:00 amRNSAppointment of Chief Financial Officer & Treasurer
2nd Dec 20147:00 amRNSTrading Update
1st Oct 20147:00 amRNSExercise of Warrants
29th Sep 20147:00 amRNSInterim Results
27th Aug 20147:00 amRNSVamousse products coming to Sainsbury's and Tesco
8th Aug 201410:30 amRNSHolding(s) in Company
5th Aug 201410:29 amRNSHolding(s) in Company
1st Aug 20145:49 pmRNSHolding(s) in Company
1st Aug 20142:40 pmRNSHolding(s) in Company
28th Jul 20145:35 pmRNSResult of Special Meeting & Director Shareholdings
16th Jul 20147:00 amRNSResult of AGM
16th Jul 20147:00 amRNSPlacing to raise £3.5m and launch of UK Vamousse
26th Jun 20147:00 amRNSFinal Results
22nd May 20144:02 pmRNSMigration of Shares
19th May 20146:15 pmRNSMigration of Shares
19th May 20147:00 amRNSVamousse product line available online across USA
30th Apr 20147:00 amRNSNatunex product launched across USA
24th Apr 20147:00 amRNSUSA Pest Control Patents Secured
8th Apr 20146:10 pmRNSDirector's Dealings
7th Apr 20144:41 pmRNSDirector's Dealings
1st Apr 20147:00 amRNSVamousse at over 4,000 Walmart Stores in USA
7th Mar 20147:00 amRNSMigration of Shares
6th Mar 201411:48 amRNSHolding(s) in Company
6th Mar 20147:00 amRNSAward of Share Options
24th Feb 20147:00 amRNSProposed Migration of Shares
18th Feb 20143:38 pmRNSResult of Special Meeting
13th Feb 20149:47 amRNSHolding(s) in Company
31st Jan 20144:26 pmRNSProposed Placing
23rd Jan 20145:58 pmRNSHolding(s) in Company
20th Jan 20147:00 amRNSHead-Lice Preventative Shampoo Coming to US Market

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.